Related references
Note: Only part of the references are listed.Phase I dose-escalation study of EZN-2208 (PEG-SN38), a novel conjugate of poly(ethylene) glycol and SN38, administered weekly in patients with advanced cancer
Amita Patnaik et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Safety, Pharmacokinetics, and Activity of EZN-2208, a Novel Conjugate of Polyethylene Glycol and SN38, in Patients With Advanced Malignancies
Razelle Kurzrock et al.
CANCER (2012)
Validation and fitness testing of a quantitative immunoassay for HIF1α in biopsy specimens
Sook Ryun Park et al.
CANCER RESEARCH (2012)
EZN-2208 (PEG-SN38) Overcomes ABCG2-Mediated Topotecan Resistance in BRCA1-Deficient Mouse Mammary Tumors
Serge A. L. Zander et al.
PLOS ONE (2012)
Potent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effects
Puja Sapra et al.
ANGIOGENESIS (2011)
Dose-dependent association between UGT1A1*28 polymorphism and irinotecan-induced diarrhoea: A meta-analysis
Zhe-Yi Hu et al.
EUROPEAN JOURNAL OF CANCER (2010)
Antiangiogenic agents and HIF-1 inhibitors meet at the crossroads
Annamaria Rapisarda et al.
CELL CYCLE (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Marked therapeutic efficacy of a novel polyethylene glycol-SN38 conjugate, EZN-2208, in xenograft models of B-cell non-Hodgkin's lymphoma
Puja Sapra et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Novel prodrugs of SN38 using multiarm poly(ethylene glycol) linkers
Hong Zhao et al.
BIOCONJUGATE CHEMISTRY (2008)
Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11 - Refractory model
Puja Sapra et al.
CLINICAL CANCER RESEARCH (2008)
VEGF-targeted therapy: mechanisms of anti-tumour activity
Lee M. Ellis et al.
NATURE REVIEWS CANCER (2008)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Levels of hypoxia-inducible factor-1α during breast carcinogenesis
R Bos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Effects of high-molecular-weight cryoprotectants on platelets and the coagulation system
I Bakaltcheva et al.
CRYOBIOLOGY (2000)
Share Paper
